By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Bruker this morning reported that it expects to post $465 million in revenue for the fourth quarter of 2011 and $1.64 billion in revenue for the full year.

The company released the preliminary results in a filing with the US Securities and Exchange Commission ahead of a presentation at the JP Morgan Healthcare Conference in San Francisco later today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.